CytRx Floats Settlement Of Cross-Country Securities Suits
Attorneys involved in a series of securities lawsuits relating to biopharmaceutical company CytRx Corp. proposed a settlement Thursday in Delaware Chancery Court of the actions, which would see an executive return...To view the full article, register now.
Already a subscriber? Click here to view full article